STAAR Surgical Stock Forecast
NASDAQ: STAAHealth CareOphthalmic GoodsUSD
Market open · Delayed 15 min · as of Oct 8, 12:04 PM ET
STAA analyst consensus
Consensus (11 analysts)
buy
Avg. price target
$28.00+26.33%
- Strong buy 0
- Buy 4
- Hold 6
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 11 Wall Street analysts covering STAAR Surgical (2026-10-08), 4 rate the stock a buy or strong buy, 6 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $28.00, with a high estimate of $37.00 and a low estimate of $19.00. The average target implies upside of 26.3% from the current price of $22.17.
The spread between the highest and lowest targets is 94.7%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for STAA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 4 | 36% |
| Hold | 6 | 55% |
| Sell | 1 | 9% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $19.00 | -14.28% |
| Average target | $28.00 | +26.33% |
| High target | $37.00 | +66.93% |